These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14713556)

  • 1. Society of Toxicologic Pathology position on histopathology data collection and audit trail: compliance with 21 CFR parts 58 and 11.
    Tuomari D; Elliott G; Kulwich B; Yarrington J; Fouillet X; Geoly F; Long P
    Toxicol Pathol; 2004; 32(1):122-3. PubMed ID: 14713556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society of Toxicologic Pathology position paper on pathology image data: compliance with 21 CFR Parts 58 and 11.
    Tuomari DL; Kemp RK; Sellers R; Yarrington JT; Geoly FJ; Fouillet XL; Dybdal N; Perry R;
    Toxicol Pathol; 2007 Apr; 35(3):450-5. PubMed ID: 17474067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory forum.
    Foster JR
    Toxicol Pathol; 2009 Apr; 37(3):269. PubMed ID: 19380838
    [No Abstract]   [Full Text] [Related]  

  • 4. Society of toxicologic pathology position paper: diet as a variable in rodent toxicology and carcinogenicity studies.
    Nold JB; Keenan KP; Nyska A; Cartwright ME
    Toxicol Pathol; 2001; 29(5):585-6. PubMed ID: 11695576
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives on pathology peer review.
    Long G
    Toxicol Pathol; 1996; 24(5):645-6. PubMed ID: 8923690
    [No Abstract]   [Full Text] [Related]  

  • 6. Best practices for reporting pathology interpretations within GLP toxicology studies.
    Morton D; Kemp RK; Francke-Carroll S; Jensen K; McCartney J; Monticello TM; Perry R; Pulido O; Roome N; Schafer K; Sellers R; Snyder PW
    Toxicol Pathol; 2006; 34(6):806-9. PubMed ID: 17162539
    [No Abstract]   [Full Text] [Related]  

  • 7. Going GLP: Conducting Toxicology Studies in Compliance with Good Laboratory Practices.
    Carroll EE
    US Army Med Dep J; 2016; (3-16):64-9. PubMed ID: 27613211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies.
    Keirstead ND; Janovitz EB; Meehan JT; LeRoy BE; Megill JR; Peterson RA; Masson RG; Marxfeld HA
    Toxicol Pathol; 2019 Jun; 47(4):461-468. PubMed ID: 31018785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best practices guideline: toxicologic histopathology.
    Crissman JW; Goodman DG; Hildebrandt PK; Maronpot RR; Prater DA; Riley JH; Seaman WJ; Thake DC
    Toxicol Pathol; 2004; 32(1):126-31. PubMed ID: 14713558
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory Forum opinion piece: image analysis-based cell proliferation studies using electronic images: the CEPA industry working group's proposal.
    Dölemeyer A; Mudry MC; Kohler M; Schorsch F
    Toxicol Pathol; 2013; 41(8):1170-3. PubMed ID: 23827979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STP debate on the desirability of an international mechanism for recognizing qualified toxicologic pathologists.
    Bolon B; Ochoa R; Mann P
    Toxicol Pathol; 2009 Dec; 37(7):992-6. PubMed ID: 19820139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory forum opinion piece*: pathology peer review--to lock or not to lock, is that really the question?
    Engelhardt JA; Hardisty JF; Mann PC
    Toxicol Pathol; 2013; 41(7):1051-2. PubMed ID: 23960166
    [No Abstract]   [Full Text] [Related]  

  • 13. Access audit trails: en route to security.
    Halpert AM
    J AHIMA; 2000 Sep; 71(8):43-6; quiz 47-8. PubMed ID: 11186622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditing drug metabolism protocols, data, and reports.
    Lucas G; Walls S
    Qual Assur; 1994 Jun; 3(2):193-7. PubMed ID: 7804636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory forum opinion piece*: pathology peer review--dilemmas of documentation.
    Kerlin RL; Schafer KA
    Toxicol Pathol; 2013; 41(7):1049-50. PubMed ID: 23960162
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicologic Pathology Forum*: Opinion on Considerations for the Use of Whole Slide Images in GLP Pathology Peer Review.
    Bradley A; Jacobsen M
    Toxicol Pathol; 2019 Feb; 47(2):100-107. PubMed ID: 30636543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving data collection.
    Daskalakis TG
    NAHAM Manage J; 1992; 17(3):14-5. PubMed ID: 10117165
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientific and Regulatory Policy Committee Review: Review of the Organisation for Economic Co-operation and Development (OECD) Guidance on the GLP Requirements for Peer Review of Histopathology.
    Fikes JD; Patrick DJ; Francke S; Frazier KS; Reindel JF; Romeike A; Spaet RH; Tomlinson L; Schafer KA;
    Toxicol Pathol; 2015 Oct; 43(7):907-14. PubMed ID: 26208968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles for developing governance reports on quality and performance.
    O'Rourke LM; Bader BS
    Qual Lett Healthc Lead; 1993 Mar; 5(2):2-7. PubMed ID: 10125554
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory forum opinion piece: Peer review documentation and pathology data locking.
    Neef N
    Toxicol Pathol; 2014; 42(2):311-3. PubMed ID: 24357644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.